See what the
eye can't.
MammoCheck pairs thermal imaging with AI to help women monitor breast health over time, surfacing changes for a clinician to review. Non‑invasive, radiation‑free, no compression.
Investigational device under development. Pursuing CE marking (MDR, Class IIa) and FDA 510(k) clearance. Designed as an adjunct to, not a replacement for, clinical screening such as mammography.
Early detection
changes everything.
01 · Why it mattersnew breast cancer cases diagnosed worldwide every year.
women will face breast cancer in their lifetime.
five‑year survival when detected at a localized stage.
Sources: WHO / IARC Globocan · American Cancer Society SEER data.
Simple.
Non‑invasive.
02 · How it worksScan
Position the thermal camera and follow the app's guided capture. No compression, no discomfort, no radiation.
Analyze
Our AI maps thermal patterns and looks for changes between your scans over time.
Track & share
Generate a clinician‑ready report to review with your doctor, and track patterns month to month.
Thermal imaging,
read by AI.
Skin temperature patterns can shift with changes in local blood flow and tissue activity. MammoCheck captures these patterns with a calibrated thermal camera and uses machine learning to surface changes that may warrant a clinician's attention. It does not detect or diagnose cancer.
VisibleThermalLife keeps moving
Monitoring that fits your routine, on your schedule.
Heat tells a story
The thermal camera reads skin temperature without contact.
AI maps the change
Patterns compared over time. Changes flagged for follow up.
Three founders.
One mission.
04 · Team
From the journey.
05 · News & milestonesMammoCheck wins 1st place at the 16th NBG Business Seeds Innovation Competition
MammoCheck took 1st place and a €20,000 award at the 16th NBG Business Seeds competition, selected among 12 winners from 344 submissions.
12 June 2026
Read more →MammoCheck wins 1st place at the Cyprus Entrepreneurship Competition (CyEC)
MammoCheck won 1st prize in the Launchpad Track at the 10th Annual Innovation and Entrepreneurship Forum (University of Cyprus), which concluded with the CyEC awards.
18 February 2026
Read more →All three co-founders named Forbes 30 Under 30, Greece 2026
Alexandra Dimitriadou, Marios Pafitis and Athina Grigoriou recognised in the Forbes 30 Under 30 Greece 2026 list for their work on breast health monitoring.
15 January 2026
Read more →Take control of your
breast health.
Be the first to know when MammoCheck becomes available in your country, and follow our clinical and regulatory progress.
Based in Cyprus? Join our clinical studies →